Acute respiratory distress syndrome (ARDS) is characterised by acute hypoxaemic
respiratory failure with bilateral infiltrates on chest imaging, which is not fully explained by …

Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

Importance The longer-term effects of therapies for the treatment of critically ill patients with
COVID-19 are unknown. Objective To determine the effect of multiple interventions for …

Despite advances in the treatment and mitigation of critical illness caused by infection with
SARS-CoV-2, millions of survivors have a devastating, post-acute infection syndrome known …

The long-term clinical management and evolution of a cohort of critical COVID-19 survivors
have not been described in detail. We report a prospective observational study of COVID-19 …

Background Survivors of acute respiratory distress syndrome (ARDS) are at risk of long-term
comorbidities. This systematic review and meta-analysis evaluated health-related quality of …

Rationale: Long-term outcomes of patients with coronavirus disease (COVID-19)–related
acute respiratory distress syndrome treated with extracorporeal membrane oxygenation …

Acute respiratory distress syndrome (ARDS) is frequently associated with sepsis. ARDS and
sepsis exhibit a common pathobiology, namely excessive inflammation. Corticosteroids are …

To compare mental, cognitive and physical outcomes between COVID-19 and non-COVID-
19 patients, 3–6 months after Intensive Care Unit (ICU) treatment during the COVID-19 …

Over the past 2 years, SARS-CoV-2 infection has resulted in numerous hospitalizations and
deaths worldwide. As young intensivists, we have been at the forefront of the fight against …